Duopharma Biotech Berhad reported earnings results for the fourth quarter and full year ended December 31, 2023. For the fourth quarter, the company reported sales was MYR 167.5 million compared to MYR 151.96 million a year ago. Net income was MYR 8.5 million compared to MYR 17.16 million a year ago. Basic earnings per share from continuing operations was MYR 0.0088 compared to MYR 0.018 a year ago. Diluted earnings per share from continuing operations was MYR 0.0088 compared to MYR 0.018 a year ago.
For the full year, sales was MYR 704.73 million compared to MYR 696.72 million a year ago. Net income was MYR 52.65 million compared to MYR 70.11 million a year ago. Basic earnings per share from continuing operations was MYR 0.0549 compared to MYR 0.0739 a year ago. Diluted earnings per share from continuing operations was MYR 0.0549 compared to MYR 0.0739 a year ago.